ZAP Surgical Raises $78M in Series E Funding Led by Baheal Medical
ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, announced today the successful closing of a $78 million Series E funding round, led by Qingdao Baheal Medical Inc., with participation from other strategic investors. The new funding…
Castle Biosciences to Present New Data on DecisionDx®-Melanoma and MyPath® Melanoma at ASDP 61st Annual Meeting
Castle Biosciences, Inc. (Nasdaq: CSTL), a leader in developing innovative tests to guide patient care, will present new data on the clinical performance of its DecisionDx®-Melanoma and MyPath® Melanoma tests at the 61st Annual Meeting of the American Society of…
Palleon Pharmaceuticals Presents GLIMMER-01 Trial Results of E-602 and Cemiplimab at SITC Annual Meeting
Palleon Pharmaceuticals, a clinical-stage company leading innovation in glyco-immunology for autoimmune diseases and cancer, today announced results from the Phase 1/2 GLIMMER-01 trial of E-602. This first-in-class human sialidase enzyme therapeutic was tested in combination with the PD-1 inhibitor cemiplimab…
Sunshine Health Announces Charlene Zein President and CEO
Sunshine Health, Florida’s largest managed care organization and a subsidiary of Centene Corporation (NYSE: CNC), has announced the appointment of Charlene Zein as Plan President and Chief Executive Officer, effective November 3, 2024. With nearly 20 years of experience in…
Tempus Launches Clinical Immune Profile Score Test
Tempus AI, Inc. (NASDAQ: TEM), a leader in AI-driven precision medicine, has announced the clinical launch of its Immune Profile Score (IPS) algorithmic test. Now available for clinicians to order, the IPS test is a multimodal biomarker designed to serve…
Square Knot Health Enhances Kidney Transplant Access, Reports at ASN Kidney Week
Square Knot Health, a leader in technology-driven kidney transplant care, has achieved outstanding results with its innovative care model designed to help patients navigate the complexities of kidney transplantation. The company’s unique approach streamlines the transplant process, improving access and…
Cofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC Immunotherapy Test
Cofactor Genomics, Inc., a clinical-stage company focused on advancing precision medicine through RNA decoding, has announced the publication of results from its PREDAPT clinical trial (NCT04510129) in head and neck squamous cell carcinoma (HNSCC). The study highlights the clinical validity…
Maravai to Acquire Officinae Bio’s DNA and RNA Business
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services, has announced an agreement to acquire the DNA and RNA business of Officinae Bio. This acquisition is expected to enhance Maravai and its subsidiary, TriLink BioTechnologies,…
GE HealthCare Launches Secondary Offering of 13.3 Million Shares
GE HealthCare Technologies Inc. (Nasdaq: GEHC) announced today the launch of a secondary underwritten public offering of 13,281,302 shares of its common stock (the “GEHC Shares”). The company is not selling any shares and will not receive any proceeds from…
BioIVT and KRISHGEN BioSystems Announce Exclusive South Asia Agreement
BioIVT, a global leader in biospecimen solutions and research support for drug and diagnostic development, has announced an exclusive partnership with KRISHGEN BioSystems. KRISHGEN, a prominent provider of life science research tools and services with over two decades of experience…
SBC Medical Group and MEDIROM Group Form Business Partnership
SBC Medical Group Holdings (California, USA, CEO: Aikawa Yoshiyuki), a provider of management support to medical institutions globally, has entered into a business partnership with MEDIROM Corporation (Headquarters: Minato-ku, Tokyo, CEO: Eguchi Koji). MEDIROM operates over 300 relaxation studios nationwide…
Guardant Health Reports Q3 2024 Results and Raises Revenue Guidance
Key Financial Highlights for Q3 2024: Recent Operating Highlights: CEO Comments: “We had another record quarter, driven by significant reimbursement tailwinds for Guardant360 and strong volume growth,” said Helmy Eltoukhy, co-founder and co-CEO. “With this momentum, we’re raising our revenue…